International Journal of Clinical Science and Medical Research

Prostatic cancers commonly metastasize to bone, leading to either osteoblastic or osteolytic lesions. In cases of osteoblastic deposits; diffuse osteosclerosis may sometimes occur. Patients with diffuse osteosclerosis may have very high bone mineral density (BMD), which can be detected by bone density scans.

This is a 65-year-old man with a diagnosis of prostatic cancer referred from a peripheral facility for chest and pelvic radiographs. The patient had complaints of severe pains involving almost all the bones in his body, this started from lower back and the pelvic bones with subsequent inability to move the limbs especially the left. The plain radiographs showed diffuse osteosclerosis to involve all the demonstrated bones with associated subtrochanteric fracture of the left femur. The patient’s total and free prostate specific antigen (PSA) were very high, the prostatic biopsy confirmed adenocarcinoma. 

We present a case of diffuse osteosclerosis in a confirmed case of prostatic cancer due to its peculiar presentation and to review the literature.

Diffuse osteosclerosis, Prostatic cancer, Metastasis, Bones.

1. Segamwengre IL, Mgori NK, Abdallah Yussuf S. Cancer of the prostate presenting with diffuse osteolytic metastatic bone lesions: a case report. J Med Case Reports. 2021; 6:425.
2. Ferly J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM: GLOBOCAN 2008 v2.0, Cancer incidence and mortality worldwide: IARC CancerBase No.10. Int Agency Res Canc.2010. http://globacan.iarc.fr
3. Dankey KL, Richardson JL, Bernstein L, Langholz B, Ross RK: Prostate cancer: trends in mortality and stage-specific incidence rates by racial/ethnic group in Los Angeles County, California (United States). Cancer Causes Control. 1995; 6:492-498.
4. Vinjamoori AH, Jagannathan JP, Shinagare AB, Taplin ME, Oh WK, Van den Abbeele AD, Ramaiya NH: A typicalmetastases from prostate cancer: 10-year experience at a single institution. Am J Roentgenol. 2012; 199:367-372.
5. Saad F, Clarke N, Colombel M: Natural history and treatment of bone complications in prostate cancer. Eur Urol. 2006; 49:429-440.
6. Melton III LJ, Lieber MM, Atkinson EJ, Achenbach SJ, Zincke H, Therneau TM, et al. Fracture Risk in Men With Prostate Cancer: A Population-Based Study. J Bone Miner Res. 2011; 26: 1808-1815.
7. Ahuja K, Lingamaneni P, Laswi H, Kumi DD, Chhabra N, Darweesh O, et al. Inpatient outcomes of pathological fractures in metastatic prostate cancer. J Clin Oncol. 2021; 39:15.
8. Ustun N, Ustun I, Ozgur T, Acti N, Aydogan F, Sumbul AT, et al. Diffuse osteosclerosis in a patient with prostate cancer. Osteoporos Int. 2014; 25:1181-1185.
9. Rajendiran G, Green L, Chhabra G. A rare presentation of prostate cancer with diffuse osteolytic metastases and PSA of 7242ng/ml. international Journal of Case Reports and Images. 2011;2:16-20.
10. Mundy GR. Metastasis to bone: Causes, consequences, and therapeutic opportunities. Nat Rev Cancer. 2002;2:584-593.
11. Smith MR, Brown GA, Saad F. New opportunities in the management of prostate cancer-related bone complications. Urol Oncol D Semin Ori. 2009;7:1-30.